dyf-2 Antibody

Basic Research Questions

• What is DYF-2 and what role does it play in cilia function?

DYF-2 is a critical protein component of the intraflagellar transport (IFT) machinery that maintains the structural and functional integrity of cilia. It can associate with IFT particle complex B while also influencing the function of complex A components, suggesting it plays an important role in the assembly of the IFT particle as a whole . The protein is essential for proper ciliary development and chemosensation in model organisms like Caenorhabditis elegans. Research using DYF-2 antibodies allows visualization of this protein in developing and mature cilia structures, which is crucial for understanding fundamental ciliary biology.

Methodological approach: To study DYF-2's function, researchers typically employ techniques such as fluorescent protein tagging (DYF-2::GFP), in combination with mutant phenotypic analysis through dye-filling assays that assess cilia structure and function .

• How is DYF-2 structurally characterized and what domains are critical for its function?

DYF-2 contains WD repeat domains that are crucial for protein-protein interactions. The protein's WD40 domain, particularly around the highly conserved glycine residue at position 361 (G361), is critical for its function in regulating IFT-B component recycling at the ciliary tip . Protein domain analysis of DYF-2 is typically performed using bioinformatics databases like SMART and Pfam .

Research methodology: When investigating specific domains, researchers often create point mutations in conserved residues (such as the G361R substitution) and analyze the resulting phenotypes to determine functional importance. Antibodies against different DYF-2 domains can be used to determine which regions interact with other IFT components.

• What are the expression patterns of DYF-2 in model organisms?

In C. elegans, DYF-2 expression is regulated by DAF-19, an RFX-type transcription factor that recognizes DNA sequence motifs (X-boxes) in promoters of ciliary genes . When visualized using GFP fusion constructs, DYF-2 can be detected uniformly in axons, cell bodies, and dendrites, with particularly strong fluorescence at the transition zones connecting cilia with dendrites, and weaker fluorescence throughout the cilia .

Research approach: To study expression patterns, researchers use transcriptional and translational DYF-2::GFP fusion constructs, with the full-length fusion showing the complete localization pattern while exon-specific constructs may show enhanced cell body localization .

• What is the relationship between DYF-2 and human WDR19/IFT144?

DYF-2 is the ortholog of human WDR19 (also known as IFT144 in Chlamydomonas). There is exceptionally high sequence conservation between DYF-2 and WDR19, indicating evolutionary importance and suggesting that studying DYF-2 in C. elegans can provide valuable insights into WDR19 functions in humans . The mouse ortholog of DYF-2, WDR19, also localizes to cilia, confirming an evolutionarily conserved role for this WDR protein in cilia development and function across species .

Research significance: DYF-2 antibodies used in model organisms can help elucidate mechanisms relevant to human ciliopathies linked to WDR19 mutations, providing a translational research connection.

Advanced Research Questions

• How do different mutations in DYF-2 affect cilia structure and function?

DYF-2 mutations produce variable phenotypes depending on their severity:

The null mutation dyf-2(m160) leads to severely truncated cilia and completely disrupted IFT transport, while the hypomorphic mutation dyf-2(jhu616) containing a G361R substitution in the WD40 domain results in almost normal cilia length with active anterograde IFT movements but impaired retrograde transport of IFT-B components .

Methodological considerations: When using antibodies to study these mutations, researchers should consider epitope availability that may be affected by protein misfolding or altered localization patterns.

• How does DYF-2 interact with IFT complex A and B components?

This suggests that DYF-2, particularly its WD40 domain, is essential for the reassociation of IFT-B with IFT-A prior to retrograde transport. This function is critical for recycling IFT-B components from the ciliary tip back to the base .

Research approach: Bimolecular fluorescence complementation (BiFC) assays can be used to visualize interactions between DYF-2 and other IFT components in living cells. Antibodies against DYF-2 and other IFT components can be used in co-immunoprecipitation experiments to identify protein-protein interactions.

• How does the BBSome control DYF-2 localization and function?

The BBSome plays a critical role in controlling DYF-2 localization and function. In bbs-1(jhu598) mutants with a G207D mutation in the BBS-1 protein, DYF-2 shows severely reduced ciliary targeting, similar to the behavior of DYF-2 G361R protein .

BiFC analyses indicate that DYF-2 localizes near BBS-1, BBS-7, and BBS-9 in native IFT particles, but the G361R mutation in DYF-2 abolishes this fluorescence complementation, demonstrating dissociation between mutant DYF-2 and the BBSome . This suggests a molecular mechanism where the BBSome facilitates efficient incorporation of DYF-2 into anterograde IFT particles.

Experimental evidence: The following data demonstrates the interdependence of DYF-2 and the BBSome:

• What are the best methods for generating and validating DYF-2 antibodies for research?

While the search results don't specifically detail DYF-2 antibody generation, standard approaches for creating antibodies against IFT proteins can be applied:

• Epitope selection: Target unique, surface-exposed regions of DYF-2, particularly avoiding highly conserved WD40 domains to reduce cross-reactivity with other WD repeat proteins.

• Expression and purification: Express recombinant DYF-2 fragments (particularly unique regions) in bacterial systems, followed by affinity purification.

• Validation methods:

  • Western blotting using wild-type and dyf-2 mutant lysates

  • Immunofluorescence comparing staining patterns in wild-type vs. mutant tissues

  • Pre-absorption tests with the immunizing peptide/protein

  • Parallel validation with GFP-tagged DYF-2 in transgenic animals

• Cross-species reactivity testing: Due to high conservation, antibodies raised against C. elegans DYF-2 may cross-react with mammalian WDR19/IFT144, which should be systematically tested.

• How can DYF-2 antibodies be used to study retrograde IFT disruption mechanisms?

DYF-2 antibodies are valuable tools for studying retrograde IFT mechanisms through several approaches:

• Immunolocalization: In wild-type cilia, DYF-2 shows uniform distribution, while in retrograde transport mutants, characteristic accumulation patterns emerge. Comparing these patterns with other IFT components reveals mechanistic insights.

• Biochemical fractionation: Using antibodies in western blots after subcellular fractionation can reveal altered distribution of DYF-2 between ciliary compartments in retrograde transport mutants.

• Co-immunoprecipitation: DYF-2 antibodies can help identify differential protein interactions in wild-type versus retrograde IFT mutants, revealing mechanistic changes in the IFT machinery.

• Temporal analysis: Immunofluorescence at different developmental stages can reveal when retrograde IFT defects first occur in different genetic backgrounds.

These approaches have shown that DYF-2 is particularly important for retrograde transport of IFT-B components, as mutations in its WD40 domain specifically impair reassociation of IFT-B with IFT-A prior to retrograde IFT .

• What experimental approaches can be used to visualize DYF-2 localization and movement in cilia?

Multiple complementary techniques can be used to study DYF-2 dynamics in cilia:

For functional studies, combining antibody staining with live imaging of fluorescently-tagged IFT components can provide insights into DYF-2's role in IFT particle assembly and movement .

• How are DYF-2/WDR19 antibodies being used to understand human ciliopathies?

DYF-2/WDR19 antibodies serve as important tools for understanding ciliopathies—human diseases resulting from ciliary dysfunction:

• Disease modeling: Antibodies help validate C. elegans and mouse models of WDR19-associated ciliopathies by confirming similar molecular mechanisms of disruption.

• Patient sample analysis: WDR19 antibodies can be used to examine protein expression and localization in patient-derived cells, helping to classify variants of unknown significance in the WDR19 gene.

• Therapeutic development pipeline:

  • Target validation: Confirming WDR19's role in disease pathways

  • Phenotypic screening: Assessing compounds that restore proper WDR19 localization

  • Mechanism studies: Understanding how treatments correct WDR19-associated defects

• Genotype-phenotype correlations: Antibodies help correlate specific WDR19 mutations with protein localization patterns and ciliary defects, explaining clinical variability.

Given the high conservation between DYF-2 and human WDR19, findings from C. elegans can provide valuable insights into human ciliopathy mechanisms .

• What research approaches are available for studying DYF-2 mutations and their effects?

Researchers employ a multi-faceted approach to study DYF-2 mutations:

• Genetic analysis: Identification and characterization of dyf-2 mutations through forward and reverse genetics .

• Transgenic rescue: Introduction of wild-type DYF-2 into mutant backgrounds to confirm gene identity and function .

• Structure-function analysis: Creation of specific point mutations (like G361R) to identify functional domains .

• Functional assays:

  • Dye-filling assays to assess ciliary integrity

  • Behavioral assays to evaluate chemosensation

  • IFT particle tracking using time-lapse microscopy

• Interaction studies:

  • BiFC to visualize protein-protein interactions in living cells

  • Co-immunoprecipitation to identify binding partners

  • Yeast two-hybrid screening to map interaction domains

• Ultrastructural analysis: Electron microscopy to visualize ciliary defects at nanoscale resolution .

• Cross-species validation: Testing conservation of function using human WDR19 in model organisms .

• How does DYF-2 expression and function compare with newer identified IFT proteins?

While DYF-2 is a well-established IFT protein, it functions within a complex network of IFT components, including more recently characterized proteins like DYF-13:

Research shows that DYF-13's ortholog in Trypanosoma brucei, PIFTC3, participates in a macromolecular complex of approximately 660 kDa and interacts with components of IFT complex B as well as other IFT factors. It also interacts with IFT122, a component of IFT complex A . This interconnected network highlights the complex coordination required for proper IFT function.

• What emerging techniques are being developed for studying DYF-2 and ciliary proteins?

Recent advancements in protein research technologies offer new opportunities for DYF-2 studies:

• Proximity labeling techniques (BioID, APEX): These methods allow identification of proteins in close proximity to DYF-2 in living cells, revealing transient or weak interactions within the ciliary environment.

• Super-resolution microscopy: Techniques like STORM and PALM enable visualization of DYF-2 localization and movement at nanoscale resolution, surpassing the diffraction limit of conventional microscopy.

• Cryo-electron microscopy: This approach enables visualization of native IFT complexes containing DYF-2 at near-atomic resolution, providing structural insights into how mutations affect complex assembly.

• CRISPR-based approaches: Precise genome editing allows creation of endogenously tagged DYF-2 to study its dynamics without overexpression artifacts.

• Single-molecule tracking: This technique enables visualization of individual DYF-2 molecules in living cells, providing insights into its movement and interactions at the single-molecule level.

• Machine learning approaches for protein design: Similar to the DyAb model used for antibody design , computational approaches could identify optimal epitopes for DYF-2 antibody generation or predict the effects of specific DYF-2 mutations.

• How do antibody-based approaches compare with genetic techniques for studying DYF-2 function?

Both antibody-based and genetic approaches offer complementary insights into DYF-2 function:

For comprehensive DYF-2 studies, researchers typically employ both approaches - using genetic techniques to establish function and antibody-based methods to study molecular mechanisms and interactions with other IFT components .